All In Biotech

Free tool

FAERS Monitor: Heparin Sodium 25,000 Units In Sodium Chloride 0.45% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019953 or its brand name (Heparin Sodium 25,000 Units In Sodium Chloride 0.45% In Plastic Container, Heparin Sodium). Reports on generic versions are filed under their own applications.

Reports

22

Serious

19

86% of reports

Hospitalization

11

Death reported

5

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective7
  • somnolence6
  • abdominal pain5
  • asthenia5
  • blood test abnormal5
  • death5
  • fatigue5
  • gastrooesophageal reflux disease5
  • haemoptysis5
  • pulmonary embolism5
  • vomiting5
  • abdominal distension4
  • activated partial thromboplastin time prolonged4
  • anaemia4
  • aortic stenosis4

Reports by year received

View as table
YearReports
20171
20195
20201
20213
20222
20233
20241
20266

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,137 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
aortic stenosisSignal41099.4452.83,357
activated partial thromboplastin time prolongedSignal4755.9311.42,307
blood test abnormalSignal5340.4157.51,370
haemoptysisSignal5171.479.3686
gastrooesophageal reflux diseaseSignal559.427.5232
pulmonary embolismSignal550.323.3196
abdominal distensionSignal436.615.1106
somnolenceSignal628.514.4134
abdominal painSignal520.59.575
anaemiaSignal420.18.355
astheniaSignal512.75.944
vomitingSignal510.24.733
fatigueSignal56.12.817
deathSignal55.52.615
drug ineffectiveSignal75.12.820

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.